Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Gad Berdugo
General Partner,
Explorium Capital LLC

Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Michael Tew
Principal
SandHill RP

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

FDA takes step to improve generic drug competition

FDA takes step to improve generic drug competition

“This is a good circumstance of the FDA actually getting out in front of a problem before it becomes serious,” said Peter...  Read more

Why People Don't Trust Drug Makers

Why People Don't Trust Drug Makers

The subtext here is clear: Americans think price-gouging on prescription medicines is rampant. ...  Read more

Single-payer health care unworkable, too costly

Single-payer health care unworkable, too costly

The real problem with a single-payer system, however, is much simpler: The approach has failed everywhere it has been tri...  Read more

DRUGWONKS BLOG